Novartis, Teva End Long-Running Lotrel Patent Suit
Novartis Corp. and Teva Pharmaceuticals USA Inc. buried the hatchet Wednesday in a seven-year-old patent dispute in New Jersey over hypertension drug Lotrel, with a federal judge approving a settlement....To view the full article, register now.
Already a subscriber? Click here to view full article